Invictus RG (Singapore)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-180
Closed -$13K 208
2015
Q3
$13K Buy
180
+26
+17% +$1.86K 0.01% 516
2015
Q2
$10K Sell
154
-46
-23% -$3.18K 0.01% 559
2015
Q1
$15K Sell
200
-2,208
-92% -$172K 0.01% 490
2014
Q4
$179K Sell
2,408
-1,162
-33% -$81.5K 0.19% 203
2014
Q3
$210K Sell
3,570
-2,036
-36% -$129K 0.27% 172
2014
Q2
$374K Buy
5,606
+5,296
+1,708% +$337K 0.39% 59
2014
Q1
$19K Buy
+310
New +$18.5K 0.02% 493

Other funds holding IDXX

Invictus RG (Singapore)'s IDXX Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Idexx Laboratories (IDXX) in Q4 2015, closing a stake of 180 shares — an estimated $13K sold.

Invictus RG (Singapore) first reported a position in IDXX in Q1 2014 and held it in 7 quarters. The position peaked at $374K in Q2 2014. 351 funds tracked by Wall St. Rank hold IDXX as of Q4 2015.

  • Invictus RG (Singapore) reported no remaining Idexx Laboratories position as of Q4 2015 after selling out during the quarter.
  • Invictus RG (Singapore) sold 180 Idexx Laboratories shares in Q4 2015, an estimated $13K.
  • Invictus RG (Singapore) first reported a position in Idexx Laboratories in Q1 2014 and held it in 7 quarters.
  • Invictus RG (Singapore)'s Idexx Laboratories position peaked at $374K in Q2 2014.
  • 351 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.